Browsing by Author "XX590463"

Now showing items 1-20 of 32

    • Acute and fulminant hepatitis induced by flutamide: Case series report and review of the literature 
      Brahm Barril, Javier; Brahm, Magdalena; Segovia, Roberto; Buckel González, Erwin; Latorre, Ricardo; Poniachik Teller, Jaime; Zapata, Rodrigo; Contreras, Luis (MEXICAN ASSOC HEPATOLOGY, 2011)
      Flutamide is a non-steroidal anti-androgenic drug, commonly used in the treatment of advanced prostate cancer, acne and hirsutism. This drug may induce various degrees of liver injury, including acute liver failure (ALF), ...
    • Cirrosis biliar primaria: experiencia de trece años en dos centros de referencia 
      Valera M., José Miguel; Smok Sahid, Gladys; Poniachik Teller, Jaime; Oksenberg Reisberg, Danny; Silva P., Guillermo; Ferrario B., Mario; Buckel González, Erwin; Brahm Barril, Javier (2006)
      Background: Primary biliary cirrhosis (PBC) is a chronic cholestatic disease, which can progress to hepatic failure. Aim: To study the clinical presentation, pathological features, treatment and outcome of a group of ...
    • A comparative analysis of the Spanish and Latin-American prospective drug-induced liver injury (DILI) networks 
      Bessone, Fernando; Hernandez, Nelia; Sánchez Ciceron, Adriana; Di Pace, Maria; Gualano, Gisela; Arrese, Marco; Ruiz, Alex; Loaeza del Castillo, Aurora; Girala, Marcos A.; Carrera, Enrique; Lizarzabal, Maribel; Mengual, Edgardo; Brahm Barril, Javier; Arancibia, Juan P.; Tanno, Federico C.; Davalos Moscol, Milagros B.; Parana, Raymundo; Schinoni, M. I.; Méndez Sánchez, Nahum; Garassini, Miguel E.; Zapata, Rodrigo L.; Medina Cáliz, I.; Gonzalez Jimenez, Andres; Robles Diaz, Mercedes; Stephens, C.; Ortega, A.; Sanabria, Judith; Garcia Cortes, Miren; García Muñoz, B.; Lucena, M. I.; Andrade, Raul J. (Wiley & Sons, 2015)
    • Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids 
      Robles Díaz, M.; González Jiménez, A.; Medina Cáliz, I.; Stephens, C.; García Cortés, M.; García Muñoz, B.; Ortega Alonso, A.; Blanco Reina, E.; González Grande, R.; Jiménez Pérez, M.; Rendon, P.; Navarro, J. M.; Gines, P.; Prieto, M.; García Eliz, M.; Bessone, F.; Brahm Barril, Javier; Paraná, R.; Lucena, M. I.; Andrade, R. J. (John Wiley, 2015)
      Background We have observed an increase in hepatotoxicity (DILI) reporting related to the use of anabolic androgenic steroids (AAS) for bodybuilding. Aim To characterise phenotype presentation, outcome and severity of ...
    • Distribución nacional y regional de genotipos del virus hepatitis C en Chile 
      Venegas Santos, Mauricio; Torres, Claudio; Urzúa Manchego, Álvaro; Brahm Barril, Javier (2013)
      Genotyping of hepatitis C virus has an important prognostic value for response to antiviral therapy. The results of hepatits C virus genotyping performed between 1994 and 2012 from 1,766 patients of different regions ...
    • Enfermedad celíaca del adulto:Experiencia clínica 
      Mancilla Asencio, Carla; Madrid Silva, Ana; Valenzuela Escobar, Jorge; Morales Barria, Antonio; Hurtado Heim, Carmen; Smok Sahid, Gladys; Ledezma R., Rodrigo; Castillo Montecinos, Iván; Rivas Q., Mauricio; Brahm Barril, Javier (Sociedad Médica de Santiago, 2005-11)
      The prevalence of celiac disease (CD) is unknown in Chile. We have recently noted a rise in the number of cases diagnosed among adults. Aim: To describe the clinical characteristics of a group of adult celiac patients. ...
    • Gastrointestinal and hepatobiliary manifestations in patients with common variable immunodeficiency: In ... 
      Navea, César; Echeverría, Matías; Romero, César; Osse, Emily; Brahm Barril, Javier; Poniachik Teller, Jaime (Ediciones Doyma, S.L., 2019)
    • Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment 
      Venegas Santos, Mauricio; Brahm Barril, Javier; Villanueva Arancibia, Rodrigo (2012)
      Hepatitis C virus (HCV) is an important global health problem with an estimated prevalence of more than 170 million infected individuals worldwide. Currently, the standard antiviral therapy, based on pegylated interferon ...
    • Genotype F of hepatitis B: response to interferon 
      Venegas Santos, Mauricio; Poniachik Teller, Jaime; Fuster, Francisco; Hurtado Heim, Carmen; Villanueva, Rodrigo A.; Brahm Barril, Javier (2015)
    • Hepatitis aguda por virus C: reporte de siete casos en centro de referencia en Chile 
      Urzúa Manchego, Álvaro; Araneda, Gonzalo; Venegas Santos, Mauricio; Arancibia, Juan Pablo; Brahm Barril, Javier; Poniachik Teller, Jaime (Sociedad Médica de Santiago, 2020)
      Hepatitis C virus infection is a major global public health problem. Treatment with direct-acting antivirals is intended to eradicate the chronic form of this infection by 2030. Although uncommon, the acute form of ...
    • Hepatitis crónica por virus C:factores asociados a la severidad del daño histológico 
      Orellana N., Ivonne; Poniachik Teller, Jaime; Smok Sahid, Gladys; Madrid Silva, Ana; Menéndez A., Alejandra; Tobar Almonacid, Eduardo; Brahm Barril, Javier (Sociedad Médica de Santiago, 2005-11)
      Twenty percent of patients with chronic hepatitis C evolve to cirrhosis in 10 to 20 years. The degree of steatosis and hepatic iron stores in liver biopsy increase the risk. Age, high body mass index, diabetes mellitus ...
    • Hepatitis E virus seroprevalence in blood donors in a university hospital in Chile Seroprevalencia de virus ... 
      Covarrubias Ruz, Natalia; Naveas, Paulina; Miranda, Julio; Hurtado, Carmen; Vera, Daniela B.; Larrondo, Milton; Brahm Barril, Javier; Luca Venegas, Mauricio Pascual de (Sociedad Chilena de Infectologia, 2018)
      © 2018, Sociedad Chilena de Infectologia. All rights reserved. In Chile, there are few studies about seroprevalence of IgG antibodies against hepatitis E virus (HEV) in blood banks, between 4 and 8%. The development of new ...
    • IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment‑naive patients with ... 
      Mangia, Alessandra; De Ledinghen, Víctor; Bailly, Francois; Brahm Barril, Javier; Keiss, Jazeps; Valantinas, Jonas; Rasmann, Nele; Messinger, Diethelm; Tatsch, Fernando; Bakalos, Georgios; Foster, Graham (Springer, 2016)
      Background and purpose: Contradictory data exist on the association between host interleukin-28B (IL28B) rs12979860 genotype and liver fibrosis in patients with chronic hepatitis C (CHC). This large, international, ...
    • IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients 
      Venegas, Mauricio; Villanueva, Rodrigo A.; González, Katherine; Brahm Barril, Javier (2011)
      AIM: To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus (HCV)). METHODS: We studied two groups of patients with chronic ...
    • IL28B polymorphisms associated with therapy responsee in Chilean chronic hepatitis C patients 
      Venegas Santos, Mauricio; Villanueva Arancibia, Rodrigo; González Lagos, Katherine; Brahm Barril, Javier (2011)
      AIM: To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus (HCV). METHODS: We studied two groups of patients with chronic ...
    • Interferon lambda 4 rs12979860 C>T polymorphism is not associated with liver fibrosis in patients with ... 
      Brahm Barril, Javier; Urzúa Manchego, Álvaro; Poniachik Teller, Jaime; Cáceres, Dante D.; Carreño, Laura; Luca Venegas, Mauricio Pascual de (Sociedad Medica de Santiago, 2018)
      © 2018, Sociedad Medica de Santiago. All rights reserved. Background. Host genetic predispositions may be important determinants of liver fibrosis in patients with chronic hepatitis C (CHC). The association between ...
    • Interferones lambdas (ifnsλ) en infección con virus hepatitis C 
      Torres B., Claudio; Venegas Santos, Mauricio; Brahm Barril, Javier (2011)
      The current standard therapy for patients chronically infected with hepatitis C virus (HCV) is the administration of pegylated interferon-α (PEG-IFN) plus ribavirin (RBV), eliminating the virus in only about half of ...
    • Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review 
      Arab, Juan P.; Candia, Roberto; Zapata, Rodrigo; Muñoz, Cristián; Arancibia, Juan P.; Poniachik Teller, Jaime; Soza, Alejandro; Fuster, Francisco; Brahm Barril, Javier; Sanhueza, Edgar; Contreras, Jorge; Cuellar, M. Carolina; Arrese, Marco; Riquelme, Arnoldo (WJG Press, 2014)
      © 2014 Baishideng Publishing Group Inc. All rights reserved.AIM: To build a consensus among Chilean specialists on the appropriate management of patients with nonalcoholic fatty liver disease (NAFLD) in clinical practice. ...
    • Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa en pacientes cirróticos: estudio ... 
      Silva P., Guillermo; Quera Pino, Rodrigo; Fluxá G., Fernando; Sanhueza B., Edgar; Segovia M., Roberto; Brahm Barril, Javier; Muñoz, Cristián; Morales Barria, Antonio; Muñoz Clavijo, Lorena; Urzúa F., Luis; Biagini A., Leandro (SOC MEDICA SANTIAGO, 2004-03)
      Acute variceal bleeding in cirrhotic patients is an emergency with a high risk of rebleeding and death. Endoscopic procedures such as sclerotherapy or banding, combined or not with drugs such as octreotide could be ...
    • Pancreatitis autoinmune: Experiencia clínica y revisión de la literatura 
      Muñoz C., Sergio; Mancilla Asencio, Carla; Moyano Schlegel, Leonor; Castillo T., Cecilia; Rossi F., Ricardo; Brahm Barril, Javier; Berger Fleiszig, Zoltán (2010)
      Background: Autoimmune pancreatitis is a special form of chronic pancreatitis, more common in men and usually presenting as obstructive jaundice or abdominal pain. It may be associated with other immunological disorders ...